Determine the onset of sepsis days before clinical symptoms appear in the patient.
Diagnosed cases of sepsis exceed 18 million a year with 1,400 patients dying daily in the developed world. Rapid treatment is critical to a patient’s recovery and therefore the time taken to diagnose sepsis is key.
This new technique is not dependent upon needing the symptoms of sepsis to be clinically displayed. Instead, a set of biomarkers are used in suspected patients to diagnose the presence of sepsis before the symptoms appear.
This allows the identification of sepsis in a patient much earlier, extending the treatment window and making it more effective.
- Therapeutic window extended and mortality rates reduced
- Cost of treatment lowered
- Can discriminate between sepsis, SIRS, and negative controls
- Compatible with RT-qPCR formats for rapid results